Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,409,200
Percent of class
8.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-19-000144
Form type
SC 13G
Filer
GOLDMAN SACHS GROUP INC
CIK
CIK 886982
Filed
Feb 07, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub